SCHEMBL22493349

SCHEMBL22493349

CCc1ncccc1CCNC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.35
MTNR1A P48039 1/20 0.31
ALDH1A1 P00352 4/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
GCK P35557 1/20 0.30
LMNA P02545 1/20 0.30
TAAR1 Q96RJ0 1/20 0.30
ALOX15 P16050 1/20 0.30
P2RY1 P47900 1/20 0.30
SSTR4 P31391 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22493402 0.80 P2RX7 (0.37) GRM5
SCHEMBL26854073 0.78 SLC13A5 (0.49) KDM4EHPGDMEN1KMT2AHTR2A
SCHEMBL22493346 0.77 ALDH1A1 (0.33) GRM5MTNR1AALDH1A1KDM4EHRH3
SCHEMBL13964873 0.77 GRM5 (0.49) GRM5ALDH1A1KDM4EL3MBTL1
SCHEMBL5786722 0.77 GABRA1 (0.39) GRM5ALDH1A1KDM4EMAPTLMNA
SCHEMBL22493867 0.76 CD38 (0.38) MTNR1AALDH1A1KDM4ETAAR1P2RY1
SCHEMBL26853974 0.76 MAPK1 (0.34) MTNR1AALDH1A1KDM4EHPGDHRH3
SCHEMBL22493463 0.76 HTR2A (0.48) MTNR1AHTR2AHTR2C
SCHEMBL22864232 0.76 HDAC6 (0.46) ALDH1A1KDM4EMEN1MAPTKMT2A
Hydrochloric Acid SCHEMBL11418386 0.75 GRM5 (0.37) GRM5ALDH1A1KDM4EHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137506-A1 COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS CURASEN THERAPEUTICS, INC. (US) 2024-06-27 WO disclosed
WO-2023225021-A1 COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) CURASEN THERAPEUTICS, INC. (US) 2023-11-23 WO disclosed
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed